Related Experiment Videos
Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy
Y Terada1, T Yamada, O Nakashima
1Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
Abstract:
This study investigated the mRNA expression of the platelet-derived growth factor (PDGF) A-chain and B-chain and PDGF-beta receptor in glomeruli of 15 immunoglobulin A (IgA) nephropathy kidneys and those with minimal-change lesion (N = 7), membranous nephropathy (N = 3), and focal segmental glomerulonephritis (N = 5), by using competitive RT-PCR methods. The level of PDGF B-chain and beta receptor mRNA expression in IgA nephropathy was significantly higher than in the other forms of glomerulonephritis, but mRNA expressions of PDGF A-chain were not significantly different. Significant correlations were observed between the urinary protein level and the mRNA level of PDGF-beta receptor expression and PDGF B-chain expression, and between the serum creatinine level and the mRNA level of PDGF-beta receptor expression. The PDGF B-chain and beta-receptor may be upregulated and accelerate cell proliferation in a paracrine or autocrine manner and may play a role in the pathogenesis of IgA nephropathy.
Insights
Platelet-derived growth factor (PDGF) B-chain and beta-receptor mRNA levels are elevated in IgA nephropathy, correlating with disease severity. These findings suggest PDGF B-chain and beta-receptor play a role in IgA nephropathy pathogenesis.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Immunoglobulin A (IgA) nephropathy is a common glomerular disease.
- Glomerular cell proliferation is a key feature in IgA nephropathy pathogenesis.
- Platelet-derived growth factor (PDGF) signaling is implicated in kidney diseases.
Purpose of the Study:
- To investigate the mRNA expression of PDGF A-chain, B-chain, and PDGF-beta receptor in IgA nephropathy glomeruli.
- To compare PDGF mRNA expression in IgA nephropathy with other glomerulonephritis types.
- To determine correlations between PDGF mRNA expression and clinical parameters in IgA nephropathy.
Main Methods:
- Competitive RT-PCR was used to quantify mRNA levels.
- Glomeruli from IgA nephropathy and other glomerulonephritis kidney biopsies were analyzed.
- Urinary protein and serum creatinine levels were assessed.
Main Results:
- PDGF B-chain and beta-receptor mRNA expression were significantly higher in IgA nephropathy compared to other glomerulonephritis.
- PDGF A-chain mRNA expression showed no significant difference.
- Urinary protein and serum creatinine levels correlated with PDGF B-chain and beta-receptor mRNA expression.
Conclusions:
- PDGF B-chain and beta-receptor are upregulated in IgA nephropathy.
- Upregulated PDGF B-chain and beta-receptor may contribute to IgA nephropathy pathogenesis through cell proliferation.
- PDGF B-chain and beta-receptor represent potential therapeutic targets in IgA nephropathy.